Original Research
Accepted on 13 Feb 2026
Antidepressant-like effects of Rg1 by Mycn: promotion of neurogenesis in the hippocampus
in Neuropharmacology
Frontiers in Pharmacology
Type at least 3 characters
2,653 articles
articles
Editorial
Published on 13 Feb 2026
Editorial: Model organisms in neuropharmacology 2024
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1800010
- 204 views
Review
Published on 12 Feb 2026
Dimethyl fumarate and mitochondrial physiology: implications for neurological disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1748360
- 338 views
Original Research
Published on 12 Feb 2026
Parabrachial calcitonin gene-related peptide neurons sex-specifically modulate behavior in anxiety assays during alcohol withdrawal
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1750956
- 388 views
Mini Review
Accepted on 11 Feb 2026
Bridging the Translational Gap in Systems Neuroscience: From 1 Circuit Mechanisms to Clinical Therapeutics
in Neuropharmacology
Frontiers in Pharmacology
- 214 views
Review
Accepted on 11 Feb 2026
Review of Clinical Advances in the Procedural Sedation Application of Remimazolam
in Neuropharmacology
Frontiers in Pharmacology
Original Research
Accepted on 11 Feb 2026
Trazodone effectiveness in depression (TED): a comparative evaluation of effect sizes trazodone extended release and SSRIs in the treatment of major depressive disorder
in Neuropharmacology
Frontiers in Pharmacology
- 104 views
Mini Review
Published on 11 Feb 2026
From dopamine to muscarine: xanomeline-trospium (KarXT) as a novel direction in the psychopharmacotherapy of schizophrenia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1774437
- 571 views
Review
Published on 11 Feb 2026
Review of neuroprotective potential of natural products against hypoxia-induced neuronal injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1746683
- 311 views
Correction
Published on 11 Feb 2026
Correction: Advances in pharmacokinetic-pharmacodynamic modeling for anesthesia, 1987–2024: a review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1804067
- 236 views
Original Research
Published on 10 Feb 2026
Immunosuppressant treatment reduces cocaine-induced behavioral sensitization in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1757023
- 563 views
Original Research
Published on 10 Feb 2026
Metabolomic analysis of plasma and brain tissues in fentanyl-induced conditioned place preference mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1759491
- 400 views
Original Research
Accepted on 09 Feb 2026
Adenosine A2A Receptors Regulate D2-type Medium Spiny Neurons in the Nucleus Accumbens to Mediate Pain and Depression Comorbidity
in Neuropharmacology
Frontiers in Pharmacology
Original Research
Accepted on 06 Feb 2026
Intranasal Delivery of the NMDA Receptor Antagonist MK-801 Attenuates Ultra-Acute Excitotoxic Neurochemical Responses After Concussion in Rats: Comparative Pharmacological Evaluation Against Ketamine
in Neuropharmacology
Frontiers in Pharmacology
- 175 views
Clinical Trial
Accepted on 06 Feb 2026
Serum levels of S100B in patients with chronic schizophrenia during treatment augmentation with sarcosine: results of the double-blind, randomized, placebo-controlled PULSAR study
in Neuropharmacology
Frontiers in Pharmacology
- 124 views
Review
Accepted on 04 Feb 2026
Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological tools
in Neuropharmacology
Frontiers in Pharmacology
- 193 views
Original Research
Published on 03 Feb 2026
Beyond antipsychotic efficacy and toward an individualized therapeutic strategy: analysis of the systemic, metabolic, and inflammatory effects of olanzapine, haloperidol, and their combination in schizophrenic patients
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1727959
- 528 views
Original Research
Accepted on 02 Feb 2026
Nervonic Acid Confers Neuroprotection in a Zebrafish Model of Diabetic Neuropathy by Promoting Myelin Repair and Metabolic Modulation
in Neuropharmacology
Frontiers in Pharmacology
- 158 views
Review
Published on 02 Feb 2026
Advances in pharmacokinetic-pharmacodynamic modeling for anesthesia, 1987–2024: a review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1741851
- 676 views
Original Research
Accepted on 30 Jan 2026
Rescue of cognitive and negative-like symptoms by chronic aripiprazole treatment in a 3-hit mouse model of neurodevelopmental disorder
in Neuropharmacology
Frontiers in Pharmacology
- 407 views
Review
Published on 29 Jan 2026
From venom peptides to neurotherapeutics: BmK defensins and short-chain peptides as modulators of ion channels
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1754290
- 519 views
Original Research
Published on 29 Jan 2026
Legislating novel psychoactive substances: lessons from 15 years of UK mortality data (2007-2022)
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1708335
- 1,592 views
Original Research
Accepted on 28 Jan 2026
Sex-related pharmacokinetic and pharmacological responses to 4F-Furanylfentanyl
in Neuropharmacology
Frontiers in Pharmacology
- 226 views
Original Research
Accepted on 28 Jan 2026
Multifaceted Modulation of Human Opioid Receptors by Kratom Alkaloids: Binding Affinity, Functional Selectivity, and Allosteric Activity
in Neuropharmacology
Frontiers in Pharmacology
- 489 views